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Staphylococcus aureus is a major bacterial pathogen, which causes
severe blood and tissue infections that frequently emerge by au-
toinfection with asymptomatically carried nose and skin populations.
However, recent studies report that bloodstream isolates differ sys-
tematically from those found in the nose and skin, exhibiting reduced
toxicity toward leukocytes. In two patients, an attenuated toxicity
bloodstream infection evolved from an asymptomatically carried
high-toxicity nasal strain by loss-of-function mutations in the gene
encoding the transcription factor repressor of surface proteins (rsp).
Here, we report that rsp knockout mutants lead to global transcrip-
tional and proteomic reprofiling, and they exhibit the greatest signal
in a genome-wide screen for genes influencing S. aureus survival in
human cells. This effect is likely to be mediated in part via SSR42, a
long-noncoding RNA. We show that rsp controls SSR42 expression, is
induced by hydrogen peroxide, and is required for normal cytotoxicity
and hemolytic activity. Rsp inactivation in laboratory- and bacteremia-
derived mutants attenuates toxin production, but up-regulates other
immune subversion proteins and reduces lethality during experimen-
tal infection. Crucially, inactivation of rsp preserves bacterial dissemi-
nation, because it affects neither formation of deep abscesses in
mice nor survival in human blood. Thus, we have identified a spon-
taneously evolving, attenuated-cytotoxicity, nonhemolytic S. aureus
phenotype, controlled by a pleiotropic transcriptional regulator/non-
coding RNA virulence regulatory system, capable of causing S. aureus
bloodstream infections. Such a phenotype could promote deep in-
fection with limited early clinical manifestations, raising concerns
that bacterial evolution within the human body may contribute
to severe infection.
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The bacterium Staphylococcus aureus constitutes a major path-ogen causing an array of diseases including deep abscesses,
endocarditis, sepsis, and necrotizing pneumonia (1). The toll of
severe disease and mortality inflicted by S. aureus, the ongoing rise
in multiple antibiotic-resistant strains, and the prolonged hospital
stays it causes make it one of the most important human pathogens
(2, 3).
Despite much effort, the determinants of S. aureus virulence
remain incompletely understood. It is known that S. aureus can
secrete a wide range of proteins, including adhesins (4), nucleases
(5, 6), complement control proteins (7–9), and multiple toxins,
which interfere with host immune function. Toxins elicit cytotoxicity
toward a variety of cells ranging from epithelial cells to leukocytes
(1, 4, 10), and their secretion is associated with lethality in some
disease models (11–14). Additionally, some bacterial lineages, such
as USA300, display high levels of toxicity, which may be linked to
their evolutionary success (13, 15).
S. aureus asymptomatically colonizes the anterior nares of one-
third of the human population, and this bacterial reservoir rep-
resents a source for invasive infection (1, 16). However, bacterial
isolates from blood differ phenotypically from those from the
nares, exhibiting decreased cytotoxicity (17) and reduced hemo-
lysis (18). This finding is surprising because carried isolates rep-
resent the source for most human disease, and invasive and
carried isolates are closely related genetically (19). One possible
explanation for the low-hemolysis phenotype of the bloodstream
isolates involves their carrying mutations in transcription factors.
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For example, a major regulator of S. aureus cytotoxicity and he-
molysis, accessory gene regulator (agr), is known to be mutated in a
proportion of bacteria recovered from within human host cells (20–
22). Such mutants have also been noted among hospital-derived
isolates of virulent clones of S. aureus (23). They exhibit prolonged
intracellular residence due to attenuated cytotoxicity and conse-
quent delays in initiation of host cell death (24–26).
However, other genetic mechanisms might also control the
induction of an attenuated cytotoxic state. One candidate for
such a role was suggested by a study of a patient with long-term
nasal S. aureus carriage. Within this population, isolates with
reduced cytotoxicity evolved through a loss-of-function mutation
in the gene repressor of surface proteins (rsp), a gene encoding an
AraC-family transcriptional regulator. The occurrence of this
mutation accompanied the progression to a fatal bacteremia (27)
and caused a reduction in the cytotoxicity of the nasal S. aureus
population (17).
Here, we used an unbiased genome-wide screen for staphy-
lococcal genes involved in prolonged intracellular survival. We
show that rsp and the long noncoding RNA (ncRNA) SSR42
were by far the most significantly recovered genes from the
screen. We demonstrate that rsp controls SSR42 expression, is
required for normal cytotoxicity and hemolytic activity, is required
for lethality in experimental infection, and is induced by hydrogen
peroxide. Crucially, inactivation of rsp preserves bacterial dissem-
ination, because it neither affects formation of deep abscesses in
mice nor survival in human blood. Thus, we have identified a
pleiotropic transcriptional regulator/ncRNA virulence regulatory
system that controls hemolysis and cytotoxicity and a low-cytotoxic
phenotype that plays a central role in invasive S. aureus infection.
This study provides an important demonstration of how within-host
bacterial evolution can radically alter bacterial phenotypes perti-
nent to disease severity and outcome.
Results
Rsp and the ncRNA SSR42 Are Required for Intracellular Cytotoxicity
and Hemolysis of S. aureus. To identify genes mediating prolonged
intracellular survival (perhaps due to attenuated cytotoxicity) in S.
aureus, we used an unbiased genome-wide approach: We generated
a transposon mutant library pool comprising ∼25,000 independent
mutants within the highly cytotoxic isolate S. aureus 6850 (28). We
then screened it for transposon mutants that were recovered from
epithelial (HeLa) cells after internalization as described inMaterials
and Methods. Changes of frequencies of transposon insertion sites
(TIS) in the recovered bacterial pools were compared with those of
the inoculum by TIS deep sequencing, hereafter referred to as
TnSeq (Fig. 1A and SI Appendix, Fig. S1A).
We found that mutants in the rsp locus and the ncRNA SSR42
located directly upstream of rsp were significantly enriched in the
intracellular fraction (Fig. 1 B and C, Table 1, and SI Appendix,
Fig. S1 and Dataset S1) (adjusted P values 3.6 × 10−4 and 2.4 ×
10−9). Replication of rsp mutants in vitro and within HeLa cells
did not differ significantly compared with wild-type bacteria (SI
Appendix, Fig. S1 B and C). We therefore excluded differences in
intracellular growth as a reason for the frequent recovery of rsp
mutants. We also excluded differential gentamicin susceptibility
as an explanation for the enhanced survival of rsp mutants ob-
served in the screen (SI Appendix, Fig. S1D).
We therefore generated targeted mutants of rsp to study its
contribution to virulence. In S. aureus 6850, we deleted the
complete ORF, leaving the adjacent ncRNA as well as down-
stream ORFs intact (SI Appendix, SI Materials and Methods).
Furthermore, we transduced the insertional mutation within rsp,
NE1304, into a clean genomic background of S. aureus USA300
(SI Appendix, Table S5). Hemolysis and cytotoxicity are hall-
marks of S. aureus virulence, and both are regulated by the agr
quorum sensing system. However, we found that hemolysis on
sheep blood agar plates was also strongly rsp-dependent (Fig.
2A). We also noted that cytotoxicity toward epithelial cells was
rsp-dependent (Fig. 2B). We observed enhanced cytotoxicity and
hemolysis in rsp complementants relative to wild-type, likely
because of enhanced rsp expression in complementants [relative
expression level was 11.99 ± 5.16 (mean ± SD), 95% CI 6.57–
17.41)] relative to wild-type, as determined by quantitative RT-
PCR (qRT-PCR).
To analyze the kinetics of cytotoxicity, we infected HeLa with
wild-type, isogenic rsp mutants, as well as complemented mu-
tants, and compared with strains deficient in either agr or sae,
both global regulators of S. aureus virulence. We determined
intracellular cytotoxicity at 1.5, 4, 8, and 24 h after infection. agr
and sae mutants were strongly attenuated over the course of
infection (Fig. 2C). The rsp mutant was attenuated at 4 and 8 h
after infection compared with the wild-type (P = 0.015 and 0.029,
respectively), but appeared to display similar cytotoxicity after
24 h (P = 0.192) (Fig. 2C). However, rsp mutation neither influ-
ences internalization of S. aureus by HeLa cells nor phagosomal
escape (SI Appendix, Fig. S2), both of which have been shown to be
associated with cytotoxicity (29–31). Thus, our data suggest that
rsp-defective S. aureus remain within the host cell longer and delay
pathogen-induced cell death.
rsp Is Required for Lethality in Murine Infection, but Not for Abscess
Formation. Because in vitro toxicity has been linked to severe
outcome in acute mouse infection models (32), we investigated
whether rsp altered progression of experimental S. aureus in-
fection. Despite recovering rsp mutants from human bloodstream
infection, we observed reduced lethality in a lung-challenge
model when comparing survival of mice infected with either rsp
mutant, their respective wild-type, or complemented strains.
Remarkably, all mice infected with rsp mutants survived for 3 d
(Fig. 3A), whereas mortality was 100% at day 2 in the USA300
background and reached 40% in the 6850 background (SI Ap-
pendix, Fig. S3A) (P < 0.0001 and P = 0.01 for USA300 and




















































Fig. 1. A genome-wide screen for noncytotoxic S. aureus identifies rsp and
SSR42. (A) HeLa cells were infected with a mariner transposon mutant library
of S. aureus 6850. Viable bacteria were recovered from host cells 8 h after
infection and were used to reinfect epithelial cells in three consecutive en-
richment cycles. Pools of recovered bacteria and the respective inoculum
were analyzed by TnSeq. (B) Sequence reads from transposons within the
genes encoding rsp (blue) and SSR42 (red) were strongly enriched in non-
cytotoxic mutants (P < 0.001). By contrast, transposon insertions in genes
such as the drug target guaA (75) (green) were significantly depleted.
(C) Genome-wide significance (signed log10 P values) of changes in TIS fre-
quencies demonstrate that the locus encoding rsp and SSR42 is most signifi-
cantly enriched (Inset). Positive and negative values on y axis, respectively,
indicate enrichment and depletion in TIS reads compared with the inoculum.
Significant changes (adjusted P < 0.05) are highlighted in red.
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A model in which abscesses form after intravenous adminis-
tration of S. aureus (33) supported this observation (Fig. 3B).
Starting from day 2 after infection, clinical severity scores in-
creased in the mice infected with wild-type bacteria compared
with the group infected with the rsp mutant (SI Appendix, Fig. S3
B and C); severity scores on day 2 differed (P = 0.04) and on day
3 (P = 0.0002). Mice challenged with rsp wild-type bacteria also
lost more weight (SI Appendix, Fig. S3) (day 2 difference, P =
0.01) and, as in the pulmonary model, survival was significantly
reduced compared with the rsp mutant (P = 0.05) (Fig. 3B).
These results show that rsp influences bacterially induced le-
thality in vivo and that this observed mortality occurred in the
first days after experimental infection.
However, 3 h after injection of the USA300 strain, or its rsp
insertion mutant, viable bacteria were detectable in multiple
tissues, with high concentrations in liver and spleen, but with low
renal concentrations of both strains (Fig. 3C). By 48 h, both wild-
type and rsp mutant bacteria showed increased bacterial load
(Fig. 3C) and had clear histological evidence of abscess forma-
tion (SI Appendix, Fig. S4). Compatible with the similar bacterial
loads, the numbers of abscesses identified histologically were
similar. Their architecture also appeared similar (SI Appendix,
Fig. S4). This finding indicates that rsp inactivation does not
inhibit bacterial dissemination from the blood, survival, or pro-
liferation in tissues in mice.
rspMutants Are Isolated from the Human Bloodstream and Survive in
Human Blood. In a previous longitudinal study of asymptomatic
S. aureus carriage, one patient, designated patient P, was recruited
and was admitted to hospital with a S. aureus bloodstream in-
fection 15 mo after joining the study. Bloodstream isolates re-
covered from this patient differed by a small number of mutations
from the ancestor (Fig. 4A), one of which caused a stop codon in
rsp, as described (27). Subsequently, we identified a second pa-
tient, patient S, who was treated for a S. aureus bloodstream in-
fection at a hospital in Oxfordshire, United Kingdom, with a nasal
A B C
Fig. 2. S. aureus rspmutants are less hemolytic and show altered kinetics of cytotoxicity. (A) Hemolysis by S. aureus is drastically reduced in an rspmutant but
is readily restored to wild-type (WT) levels by expressing rsp in trans (Comp) in both S. aureus backgrounds, 6850 and USA300. Statistical analysis was per-
formed by one-way ANOVA and Tukey’s post hoc analysis. ***P < 0.001. (B) Host cell cytotoxicity assayed at 4 h after infection is significantly reduced in rsp
mutants compared with wild-type (WT) and complemented mutants (Comp) in infected HeLa epithelial cells for both S. aureus strains, 6850 and USA300. ni,
uninfected control. Statistical significance was determined by one-way ANOVA. *P < 0.05; ***P < 0.001. (C) Mutation within S. aureus rsp delays pathogen-
induced cytotoxicity. HeLa cells were left uninfected (control) or infected with S. aureus wild-type (USA300 WT), an isogenic rspmutant, and a complemented
mutant (USA300 Comp) along with mutants within the global regulators agrA and saeR (SI Appendix, Table S1). Kinetics of cytotoxicity were monitored over
time by propidium iodide staining and flow cytometry, here depicted on the y axis using a log scale. Statistical analysis at each time point was performed by
one-way ANOVA and Tukey’s post hoc analysis. *P < 0.05 (rsp mutant compared with wild-type).
Table 1. TnSeq screening results of S. aureus Himar1 transposon mutant library in epithelial cells
Mutant* P value† Product
Inactivated genes enriched
in intracellular S. aureus‡
ssr42 <10−6 Small stable RNA (SSR) 42
rsp 0.0004 AraC-type transcriptional regulator
geh 0.037 Glycerol ester hydrolase
ruvA 0.045 Holliday junction DNA helicase RuvA
hemL 0.050 Glutamate-1-semialdehyde aminotransferase
Inactivated genes depleted
in intracellular S. aureus
guaA 0.0003 Bifunctional GMP synthase
0220 0.0004 Transmembrane efflux pump protein, putative
pbuX 0.0004 Xanthine permease, putative
purM 0.003 Phosphoribosylformyl glycinamidine cyclo-ligase PurM
1920 0.008 ATP-dependent RNA helicase, DEAD box family, putative
2160 0.008 Phosphosugar-binding transcriptional regulator, putative
*Gene or locus IDs according to NCBI GenBank accession no. CP006706.1 (i.e., 0181 represent RSAU_000181).
†The P values were corrected for multiple testing and genes/loci showing P < 0.05 were reported as significantly
increased or decreased. For further details, see SI Appendix, Table S1.
‡Trend followed by the mutant in the given genes/loci throughout the intracellular passages of screening.















swab subsequently taken as part of routine surveillance. The
bloodstream isolate differed from the nasal isolate by only one
mutation (Fig. 4A), located in the DNA binding domain of rsp
(Fig. 4B), which is predicted to abrogate DNA binding (SI Appendix,
SI Materials and Methods). The nasal isolate carried the common
(wild-type) allele, so we considered it to be the ancestor.
Compatible with murine deep abscess formation after in-
travenous challenge, we observed that bacterial survival in human
blood was similarly rsp-independent. We inoculated wild-type or
rsp mutant bacteria into whole blood drawn from healthy human
donors and quantified viable bacterial counts over time (Fig. 4C).
The studied isolates included the highly cytotoxic S. aureus back-
ground of strain JE2 (34, 35), a member of the epidemic, highly
pathogenic methicillin-resistant S. aureus (MRSA) USA300 lineage
(ST-8), as well as the common ST-15 (patient P) and ST-59 (patient
S) lineages (SI Appendix, Table S1). Rsp-associated differences in
bacterial survival in human blood were not observed (Fig. 4C).
Thus, the enhanced early cytotoxicity observed in rsp wild-type
organisms appears dispensable for bloodstream survival and
dissemination after intravenous challenge.
rsp Is a Global Regulator of S. aureus Immune Modulators and Toxins.
The spontaneous evolution of rsp loss-of-function mutations
found in human bloodstream infections, and the rsp mutants’
capability to survive ex vivo in human blood, demonstrate that
they are not avirulent in humans. However, this observation
raises questions as to whether, in the absence of rsp, S. aureus
might elaborate an alternative set of virulence proteins other
than toxins. Rsp is a transcription regulator; hence, we tested this
hypothesis by analysis of differential transcription and protein
expression between wild-type strains and rsp mutants in three
genetic backgrounds of S. aureus isolates.
Initially, we studied bacteria from the stationary phase of growth
to minimize growth-phase specific differences between strains. In
USA300 and patient P and patient S strain backgrounds, we found
transcription to differ between loss-of-function mutants (rsp−) and
wild-type (rsp+) isolates in ∼30% of the 2,368 genes present in all
three strains, using a statistical model designed to detect con-
sistent effects of rsp mutations across strains (SI Appendix, SI
Materials and Methods). Transcription was similar across genetic
backgrounds (ρ between 0.67 and 0.79), indicating broadly con-
sistent effects of the rsp defects studied (Fig. 5A and SI Appendix,
Fig. S5). However, interactions between rsp genotype and genetic
background were also evident (Dataset S2).
Among the genes up-regulated in rsp mutants (highly regu-
lated genes in Table 2 and all results in SI Appendix, Fig. S2), we
found a strong enrichment for involvement in pathogenesis (P =
10−5.0), such as map (21.38-fold), a reported immunomodulatory
molecule (36); nuc (20.8-fold), a nuclease capable of lysing neu-
trophil extracellular traps (6); the Ig-binding protein sbi (37)
(21.22-fold); and capsule biosynthesis genes (≥21.0-fold), whose
product impedes phagocytosis (38). Genes influenced by rsp also
include reported complement inhibitors such as extracellular pro-
teases sspABC (39) (≥ 20.8-fold), the extracellular fibrinogen
binding protein efb (40) (22.08-fold), complement regulator bind
ing protein sdrE (41)(≥ 20.9-fold), and the protease aureolysin






Fig. 3. rsp mutants exhibit reduced lethality in mouse models but are ca-
pable of forming deep abscesses. (A) In a murine pneumonia model, infected
mice survived when challenged with lethal doses of rsp mutants of strain
USA300 LAC*, whereas wild-type and complemented strains were virulent
(n = 10). The comparison shown is by log-rank test between wild-type and
rsp mutant organisms. (B) In intravenous infections, mice were challenged
with S. aureus USA300 JE2 or its rsp mutant. Significantly enhanced le-
thality was seen in the wild-type relative to the mutant. (C ) Bacterial
counts in kidney, liver, and spleen were comparable 3 and 48 h after in-





Fig. 4. Low hemolytic rsp mutants are recovered from patients and occur
naturally. (A) S. aureus from bloodstream infections carry mutations in rsp. Two
bloodstream isolates were obtained from patients P and S and compared with
their respective carried strains. Isolates are represented by light (rsp+) and dark
(rsp−) gray circles. Intergenic (gray), synonymous (green), nonsynonymous (or-
ange), and nonsense (red) SNPs and indels are represented by solid and dashed
lines, respectively. Small black circles represent hypothetical intermediate geno-
types. The ordering of mutations along the branch in patient P is arbitrary.
Remarkably, only a single mutation (A204P) separated the bacteremic from a
carriage isolate in patient S. (B) Rsp is highly conserved in S. aureus and contains
a helix-turn-helix domain (amino acids 169–247). The observed substitution in
the patient S rsp− isolate (indicated in red) occurs in the center of this domain,
substituting an alanine with a proline and thereby predicted to disrupt the 3D
structure of the DNA binding region. (C) Bacterial survival with the same strains
used in Fig. 3, as well as with pairs of clinical isolates (A), was assessed after
inoculation into human blood from three healthy donors. Bacterial survival was
measured at three different time points (1, 3, and 24 h). There was no significant
difference in blood survival observed between the rsp mutant (black lines) and
wild-type bacteria (red lines). Statistical significance was determined by general
linear modeling, modeling counts at each time point as a function of rsp
genotype, and genetic background of the organism.
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cells and colonization were found to be down-regulated (sdrCD)
(43) (2−0.87 and 2−0.23-fold, respectively) (SI Appendix, Fig. S2).
Additionally, we studied transcription in the USA300 back-
ground using RNA sequencing (RNA-seq) and qPCR in both
exponential and stationary growth phases (Fig. 5B, SI Appendix,
Fig. S6, and Datasets S2 and S3). Comparing these results, we
noted that some important Rsp targets such as α-hemolysin (hla)
demonstrated decreased transcription in rsp mutants during ex-
ponential growth, but increased transcript levels during station-
ary phase (Table 3). This finding indicates that some rsp effects
may be modified by quorum-sensing mechanisms.
Rsp Influences Abundance of Secreted Proteins. Noting that Rsp
affected gene transcription of many secreted proteins (Table 2
and SI Appendix, Fig. S6), we tested whether the effect of Rsp on
transcripts was detectable at a protein level in the supernatants
of S. aureus strains ST-8 (USA300), ST-15 (patient P), and ST-59
(patient S). We compared protein abundances (Dataset S4) with
intracellular RNA levels in stationary phase (Fig. 6). For these
analyses, cells were grown in α-MEM, because this medium
afforded enhanced sensitivity of detection over growth in tryptone
soy broth (SI Appendix, Fig. S7). A high proportion (113 of 636;
18%) of the proteins detected in the supernatant of any of the
strains analyzed were affected by rsp mutation. As predicted from
functional assays, toxins [α-hemolysin Hla, γ hemolysin compo-
nents HlgA-C, the Panton-Valentine Leukocidin LukS, and
LukAB (also known as LukGH (44)] had decreased abundances in
rsp mutant organisms, as did the neutrophil chemotaxis inhibitor
CHIPS (chs gene product) (Fig. 6A). However, for a subset of
genes, including the toxins hla, lukB, and hlgB, we noted stationary-
phase RNA abundances of these genes to be significantly increased
in rsp mutant organisms (Fig. 6B). This discordance between tran-
script and protein levels, which has been previously observed in the
context of hla expression and translation, suggests the existence of
posttranscriptional control(s) (35) on toxin secretion.
Thus, Rsp has pleiotropic effects on the bacterial cell, inducing
some virulence factors (such as toxins) and significantly reducing the
concentrations of others known to be involved in pathogenesis and
complement evasion, including the ESAT-6 homolog EsxA, nuclease
(36), the complement control protein Efb (40), and lipase (Fig. 6).
Rsp Controls, and Is Adjacent to, the Highly Transcribed RNA SSR42.
Having demonstrated that Rsp controls an extensive set of genes
enriched in virulence factors, we sought to explore mechanisms
by which Rsp might exert its effects. We precisely mapped





























































































































































































































































































































































Fig. 5. rsp is a global regulator of S. aureus viru-
lence. S. aureus gene expression was measured in
stationary growth phase, showing the transcripts of
the rsp mutant relative to the wild-type. (A) Effects
of rsp mutation on gene transcription were de-
termined by DESeq2 fitting of three separate
models, one for each of three S. aureus back-
grounds, estimating effects per gene from RNA-seq
data. Concentric red rings indicate log2 fold in-
duction, and green rings repression by the mutant
relative to the wild-type. Differentially regulated
genes are shown as large dots (red, up-regulated in
mutant relative to wild-type; green, down-regu-
lated in mutant relative to wild-type) within each
strain background (USA300 and patients P and S);
see also SI Appendix, Fig. S5. (B) Transcriptomic
profiling revealed several rsp-dependently tran-
scribed genes, including the ncRNA SSR42, as well as
the virulence factor genes lukAB, chs, scpA, and hla.
We verified the relative expression of these factors
during exponential growth phase by comparing
S. aureus USA300 wild-type (WT; green), its isogenic
rsp mutant (blue), and a complemented mutant
(Comp; red), by qRT-PCR. Similar results were
obtained for stationary phase cultures as well as for
S. aureus 6850 (SI Appendix, Fig. S6). Box plots show
the median and quantiles, with whiskers indicating
the range of the data. Statistical analysis was per-
formed by one-way ANOVA and Tukey’s post hoc
analysis. **P < 0.01; ***P < 0.001. (C) The tran-
scriptome landscape at the rsp locus demonstrates
rsp-dependent transcription of the ncRNA SSR42.
RNA-seq of wild-type S. aureus USA300 (WT; green
histograms) and its isogenic rsp mutant (blue his-
tograms) demonstrated a loss of SSR42 transcription
in the absence of rsp. TSS of the wild-type S. aureus
USA300 were enriched by treatment with Termi-
nator-5′ phosphate-dependent EXonuclease (WT
TEX+; red histograms; SI Appendix, SI Materials and
Methods), because this enzyme degrades RNA
lacking a physiological 5′ terminus. Subsequent
RNA-seq revealed that SSR42, which is situated im-
mediately upstream of rsp, is transcribed in anti-
parallel direction and is 1,232 nt long.















USA300 background. This finding showed that SSR42 is situated
directly upstream of rsp and is transcribed in an antiparallel
orientation in a highly rsp-dependent manner (Fig. 5C). SSR42
expression was almost completely lost in the absence of rsp in
exponential growth (Fig. 5 B and C). RNA-seq in the stationary
growth phase showed that, in wild-type bacteria of USA300, P,
and S background, SSR42 comprised 6.4 ± 1.9% (mean ± SD) of
RNA mapping to the genome compared with 0.02 ± 0.01% in rsp
mutants. We showed SSR42 to be longer than previously noted
(45) at 1,232 nt (Fig. 5C), and as such to be the longest non-
ribosomal ncRNA identified in S. aureus.
rsp and Its Targets Are Induced by Hydrogen Peroxide. Given the
widespread effects of rsp, we decided to investigate mechanisms
of induction of the rsp regulon. Using the S. aureus Transcriptome
Meta-Database (46), we observed extensive overlap between rsp-
regulated genes and genes differentially regulated in response to
challenge with hydrogen peroxide or azurophilic granules, both




0693 6.00 Putative lipoprotein
0692 5.82 Conserved hypothetical protein
0409 5.10 Conserved hypothetical protein
1056 4.53 Conserved hypothetical protein
efb 4.23 Fibrinogen-binding protein
saeR 4.06 DNA-binding response regulator SaeR
saeS 4.00 Sensor histidine kinase SaeS
1918 3.36 Truncated β-hemolysin
hlgA 3.34 Gamma-hemolysin component A
ureC 3.23 Urease, α-subunit
0108 3.20 Antigen, 67 kDa
1052 3.182 Fibrinogen-binding protein
ureB 3.160 Urease, β-subunit
0274 3.117 Conserved hypothetical protein
0278 3.095 Conserved hypothetical protein
0273 3.031 Putative membrane protein
hlgC 3.010 Gamma-hemolysin component C
2524 3.010 Conserved hypothetical protein
0272 2.868 Conserved hypothetical protein
0238 2.848 Transcriptional antiterminator, BglG family
lukA (G) 2.828 Leukocidin LukA/G
Down-regulated
in rsp mutant
2493 0.56 Conserved hypothetical protein
2311 0.56 Conserved hypothetical protein
entB 0.55 Isochorismatase
sdrC 0.55 SdrC protein
grpE 0.54 Cochaperone GrpE
hrcA 0.53 Heat-inducible transcription repressor
2310 0.53 Conserved hypothetical protein
arsR 0.51 Arsenical resistance operon repressor
2245 0.49 Staphylococcal accessory regulator R
0372 0.48 Putative lipoprotein
0225 0.48 Putative acyl-CoA acetyltransferase FadA
fadD 0.470 Acyl-CoA dehydrogenase FadD
0226 0.463 3-hydroxyacyl-CoA dehydrogenase
arcA 0.460 Arginine deiminase
fadE 0.454 Acyl-CoA synthetase FadE
0229 0.444 Putative acyl-CoA transferase FadX
2453 0.435 ABC transporter, ATP-binding protein
2306 0.435 ABC transporter, ATP-binding protein
2307 0.297 ABC transporter, permease protein
0179 0.255 Putative D-isomer specific 2-hydroxyacid dehydrogenase
SSR42 0.004 Small stable RNA 42
*Gene symbol or last four digits of locus tag (i.e., 0238 represents SAUSA300_0238).
Table 3. Exemplar genes which show expression discordance




hla 0.48 2.57 α-Hemolysin
coa 0.05 1.16 Coagulase
chs 0.06 1.37 Chemotaxis-inhibiting protein CHIPS
sbi 0.38 2.33 IgG-binding protein SBI
lukA(G) 0.26 2.828 Leukocidin A/G
lukB(H) 0.19 2.713 Leukocidin B/H
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secretions from neutrophils (47). For example, 73 of 113 signif-
icantly peroxide-regulated genes were also rsp-regulated. Be-
cause neutrophils are one of the first cells recruited to invading
bacteria and produce bactericidal reactive oxygen species (ROS)
(48), we tested the hypothesis that rsp might be activated when
bacteria encountered the antimicrobial ROS, hydrogen peroxide.
Supporting this idea, we observed that rsp was rapidly up-regulated
in S. aureus after hydrogen peroxide treatment (22.24-fold) (Fig. 7A).
A subset of rsp target genes was similarly induced by ROS in a
clearly rsp-dependent manner, which included SSR42 (22.14
-fold), isdA (21.99-fold), lukAB (22.03-fold), scpA (21.43-fold),
hlgA (21.48-fold), hlgC (21.31-fold), and lukS-PVL (21.50-fold).
Induction of the general stress protein 20U (dps), which is known
to react to oxidative stress (47), is also partially rsp-dependent (SI
Appendix, Fig. S8A). By contrast, the genes hla (21.20-fold) and chs
(21.06-fold) were not significantly altered in the given time (Fig. 7A).
Similar trends were seen in a different strain background (SI Ap-
pendix, Fig. S8B). This finding indicates that rsp-dependent regulatory
pathways for early gene induction respond to peroxide challenge.
Because a fraction of rsp-regulated gene products are related
to immune evasion and neutrophil killing (49), we examined the
cytotoxic potential of both bacteria and bacterial supernatants
toward neutrophils. rsp-dependent neutrophil killing was evident
in both investigated strain backgrounds (Fig. 7B). Furthermore,
neutrophil cell death increased in an rsp-dependent manner,
when intoxicated with bacterial supernatants from cultures that
were challenged with hydrogen peroxide (Fig. 7C). Thus, hy-
drogen peroxide, which is also produced by neutrophils, induces
an rsp-dependent response that is directed against leukocytes.
To determine whether the ability of S. aureus to infect and
reside within neutrophils was rsp-dependent, we incubated two
strains of S. aureus with primary human neutrophils and quan-
tified intracellular S. aureus by plating. After 2 h of incubation,
rsp mutants of both genetic backgrounds were present and viable
in the neutrophils at similar amounts, indicating similar capability
to infect and reside in a viable state. Both strains grew within
neutrophils over the next 2 h, but counts were significantly higher
for wild-type than for rsp mutants (P = 0.02), compatible with
rapid bacterial replication within neutrophils, as well as neutrophil
lysis (Fig. 7 B and D), being facilitated by rsp (Fig. 7D).
Thus, rsp-dependent mechanisms detect oxidative stress, increase
bacterial replication in neutrophils, shorten intracellular bacterial
residence, and produce mediators that kill neutrophils and epithe-
lial cells. They also increase mortality in experimental infection, but
are dispensable for bloodstream infection and abscess formation.
Discussion
We have shown that naturally occurring loss-of-function mutants
in S. aureus enact global regulatory changes in gene expression
that reduce bacterial toxicity and prolong bacterial residence inside
mammalian cells, while maintaining the ability to survive, pro-
liferate, and cause disseminated infection within the human body.
Specifically, we have characterized the pleiotropic transcrip-
tion factor rsp (50), a member of the AraC family of transcrip-
tional regulators (AFTR). We found that Rsp regulates the
duration of S. aureus residence inside cells, cytotoxicity toward
epithelial cells and neutrophils, and lethality in animal models of
acute S. aureus infection (Table 4). Genome-wide screening
suggests that loss-of-function mutants in rsp and the ncRNA
SSR42 have the strongest influence among S. aureus genes on
prolonging intracellular residence of S. aureus. The prolonged
intracellular residence in the host cell cytoplasm is associated
with a delayed cytotoxicity that differs in kinetics from that seen
in mutants of the key virulence regulators, agrA and saeR mu-
tants (Fig. 2B). rsp expression is not required for dissemination
of S. aureus from the blood or for deep abscess formation, and
we have identified and characterized rsp loss-of-function mutants
found in human bacteremia. Thus, our data suggest that S. aureus
can adopt an attenuated cytotoxic phenotype, with prolonged in-
tracellular residence (51–53), which permits effective dissemination
of the organism with few initial symptoms, followed by deep abscess
establishment. The attenuated toxicity phenotype was not noted in
isolates from skin and soft tissue infection (17), suggesting that such
attenuated toxicity and intracellular survival may be particularly
important in bloodstream infection, as opposed to other forms of
infection, such as skin and soft tissue infection. Our findings that rsp
contributed to lethality in pulmonary disease is also supported by a
recent study of cutaneous S. aureus disease (54). In both models,
toxins have been shown to be key mediators of disease (13, 55).
A
B
Fig. 6. Complex rsp-dependent control mechanisms influence toxin production.
MS was performed on the supernatant of stationary phase culture of USA300
S. aureuswild-type and an rspmutant. Fold-change in the protein concentration
in rspmutant relative to wild-type organisms (x axis) was compared with protein
abundance in both wild-type and mutant organisms (A), and fold-change of
RNA expression in rsp mutant relative to wild-type organisms (B), as derived
from RNA-seq performed at the same time point. Each dot represents a gene,
and numbers denote locus identifiers (e.g., 0274 refers to SAUSA300_0274).
Open circles indicate that the effect of rsp is not significant (P > 0.05) for this
gene, whereas filled symbols indicate that the effect of rsp is significant on that
gene. The dotted lines indicate the condition where rsp mutation has no effect.
In B, the upper right quadrant identifies genes that are increased in RNA as well
as protein level. The upper left quadrant shows genes with increased RNA ex-
pression, but lower levels of protein in stationary phase. A number of important
toxins, including Hla, HlgA, HlgC, and LukB, fall within this category.















We demonstrated that Rsp and SSR42 represent a regulatory
system consisting of a protein and ncRNA in S. aureus. Structur-
ally, it consists of the two adjacent genes, in antiparallel locali-
zation and with two distinct TSS (Fig. 5C). SSR42 is an Rsp target,
as evidenced by the absence of transcription after rsp inactivation
by transposon insertion, ORF deletion, point mutation in DNA
binding domains, or translational termination, even though SSR42
comprises ∼5% of nonribosomal RNA in wild-type cells. Some of
the Rsp effects are mediated by SSR42, because SSR42-dependent
production of the Rsp targets, α-toxin, has been demonstrated
(45). Synergy of SSR42-mediated effects with direct effects of Rsp
itself, such the recently demonstrated binding of Rsp to the agr
promoter, may also occur (54).
We found that rsp transcription was induced by hydrogen perox-
ide, which is produced by neutrophils in vivo upon stimulation. This
finding suggests a model in which rsp fulfills an environment-sensing
role: On encountering phagocytes, it initiates a specific response that
consists of virulence factors that target phagocyte functions, in-
cluding α and γ hemolysins, lukAB (lukGH), and the Panton–
Valentine leukocidin. This model is compatible with the function of
other AFTR members, which, in other bacterial genera, regulate
carbon metabolism, stress responses, and virulence in response to
changing environmental conditions such as antibiotic use and stress
(56, 57). In S. aureus, the AFTRs rbf, rsr, and aryK promote biofilm
formation (58), modulate sarR and agr in a skin infection model
(59), and potentiate toxin expression and virulence (60), respectively.
Curiously, we have observed that a subset of genes (Fig. 7)
attenuated by rsp cannot be readily complemented by supplying
rsp in trans. Explanations for this phenomenon could be due to: (i)
the highly complex virulence regulatory cross-talk in S. aureus; (ii)
the involvement of posttranscriptional mechanisms, as we de-
tected by comparing transcriptomic and proteomic data (Fig. 6);
or (iii) the requirement for an SSR42-dependent cis-interaction,
and thus will require further study.
In summary, our results provide new evidence that a S. aureus
regulatory system involving the rsp transcription factor is subject to
spontaneously occurring loss-of-function mutations during evolu-
tion within the human body. These knockout mutants display at-
tenuated lethality in the initial stages of experimental infection, but
still invade deep tissues, causing severe disease. Although rsp loss-
of-function stands alone as an interesting mechanism, it has wider
significance as an example of how within-host bacterial evolution
affects key regulatory pathways, thus influencing disease progres-
sion and clinical outcome.
Materials and Methods
Transposon Mutant Library Generation and TnSeq. S. aureus strain 6850 was
transformed with plasmid pBTn, and mutagenesis was performed as described
(61). TnSeq DNA libraries were generated, and Illumina-specific adaptors were
A
B C D
Fig. 7. rsp effects are induced by hydrogen peroxide and regulate cytotoxicity toward PMNs. (A) Upon 10-min exposure to 5 mM hydrogen peroxide,
transcription of rsp and its targets is up-regulated in exponentially growing wild-type S. aureus LAC* (WT). This response to hydrogen peroxide was rsp-
dependent and rescued in complemented mutants (Comp). Values indicate expression levels of peroxide-challenged bacteria (open bars) relative to untreated
controls (filled bars). Statistical analysis was performed by pairwise t test. *P < 0.05; **P < 0.01; ***P < 0.001. (B) Bacterial infection of PMN with wild-type, rsp
mutant, and complementants, as well as treatment with bacterial culture supernatant for 4 h, demonstrated that host cell death levels were significantly
decreased and complementable in rsp mutants. Statistical significance was determined by one-way ANOVA and Tukey’s post hoc analysis. *P < 0.05; **P <
0.01; ***P < 0.001. (C) S. aureus culture supernatants collected from wild type, rsp mutant, and complementants after peroxide challenge exhibit increased
cytotoxic potential in an Rsp-dependent manner. Human PMNs were intoxicated with the supernatants, and cytotoxicity was determined by LDH release. The
vertical axis indicates the percentage of neutrophil cell death compared with complete cell lysis (positive control). Statistical analysis was performed by
pairwise t test. *P < 0.05. (D) S. aureus (strains 6850 and USA300) rspwild-type (WT), rspmutant, and complementants (Comp) were used to infect neutrophils.
Intracellular bacteria were recovered 2 and 4 h after infection, and number of viable bacteria was determined. Statistical analysis at each time point was
performed by one-way ANOVA and Tukey’s post hoc analysis. *P < 0.05 (rsp mutant compared with wild type).
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ligated to the fragments, and these were enriched for TIS by PCR. After se-
quencing on the Illumina Hi-Seq 2500 platform, sequences were mapped (62)
to the S. aureus 6850 genome (63), and differences in frequencies between the
samples were detected with DEseq2 (64). For further details, see SI Appendix, SI
Materials and Methods.
Infection Screens with S. aureus Transposon Mutant Libraries. For in vitro cell
death screens, HeLa cell monolayers were infected for 1 h with pooled mutant
libraries of S. aureus 6850 at a multiplicity of infection (MOI) of 1. Extracellular
bacteria were removed by using 20 μg/mL Lysostaphin (AMBI) and 100 μg/mL
gentamicin (GIBCO) for 30 min. The infected cells were further incubated for 8 h
in RPMI medium containing 100 μg/mL gentamicin to inhibit extracellular growth
of bacteria that were released by host cell disruption. The bacteria were recovered
(output) by hypoosmotic rupture of the HeLa cells using sterile water and plated
onto tryptone soy agar plates; including the inoculum (input), this process com-
pleted one cycle of infection. Thereby, the screening process selected for in-
tracellular noncytotoxic bacteria, because if the bacteria killed the epithelial cells
or escaped extracellularly, they were killed by gentamicin and thus were not re-
covered on the agar plates. A three-cycle infection method was adopted to enrich
the subsequent effects. The output from one cycle was used as input for the next
cycle. All three outputs and the input were subjected to TnSeq (see above).
Clinical Samples. S. aureus strains were isolated from two patients with
concomitant nasal carriage and bloodstream infection. Patient P was
recruited to a previously reported longitudinal study of asymptomatic car-
riage among adults attending general practices in Oxfordshire, U.K., de-
veloping a S. aureus bloodstream infection 15 mo after joining the study
(27). Patient S was treated for a S. aureus bloodstream infection at a hospital
in Oxfordshire, with a nasal swab subsequently taken as part of routine
surveillance. Microbiological processing was performed as described (27).
DNA was extracted by using a commercial kit (FastDNA; MP Biomedicals).
Genome Sequencing, Assembly, and Variant Calling. We used the Illumina
HiSeq 2000 platformwith 96-foldmultiplexing, read lengths of 100 or 150 bp,
insert sizes of 200 bp, and mean depth of 125 reads. As described (27), we
used Velvet (65) to assemble reads into contigs de novo for each genome.
We used Stampy (66) to map the reads of each isolate against MRSA252 (67)
and a host-specific draft genome assembled by Velvet. We used xBASE (68)
to annotate the draft genome assemblies. SAMtools (69) and Picard
(broadinstitute.github.io/picard/) were used to call single-nucleotide poly-
morphisms (SNPs) from mapping, which we filtered by using published cri-
teria (27). We additionally used Cortex (70) to detect SNPs and indels.
RNA Extraction, RNA-Seq, and Real-Time RT-PCR. Bacterial mRNA was extracted by
using TRIzol (71) or RNeasy (QIAGEN), and reverse transcription was performed
according to manufacturer’s guidelines (QIAGEN/Superscript II; Invitrogen). For
determination of TSS, processed transcripts were depleted by using Terminator
5′-phosphate-dependent exonuclease (TEX) kit (Epicentre) as described (72). The
cDNA was sequenced on the Illumina HiSeq 2000/2500 platforms, and reads
were adapter-removed, trimmed, and mapped to the respective bacterial ge-
nomes. DESeq2 (64) was used to analyze differential gene expression.
Proteomics. Proteins were precipitated from bacterial culture supernatant,
resolubilized, and digestedwith trypsin. Desalted peptideswere separated on
a Dionex Ultimate 3000 UPLC system (Thermo Scientific) and introduced to a
TripleTOF 5600 mass spectrometer (AB Sciex) by electrospray ionization.
Collision-induced dissociation-fragment data were converted to MASCOT
format, and MS/MS spectra were interpreted with PEAKS (73). The reference
protein database used for identification is provided in Dataset S5. Statistics
was performed with DESeq2 (64).
Infection Experiments. HeLa cells were seeded in tissue culture microwell
plates (Corning) or in μ-Plate ibiTreat (ibidi) and infected with S. aureus at a
MOI of 10. The extracellular bacteria were removed by treatment with
Lysostaphin and gentamicin for 30 min and further incubated with genta-
micin. Cell death was measured by staining with Annexin-V/PI/7-AAD. Hu-
man neutrophils were infected with S. aureus (74) at a MOI of 10. Cell death
was measured by lactate dehydrogenase (LDH) assay, and bacterial titers
were enumerated to see intraphagosomal survival.
Female BALB/c mice 8 wk of age were administered S. aureus either
intravenously through the lateral tail vein (sepsis model) or intranasally
(pneumonia model), with previously titrated bacterial suspensions. Weight
and clinical score were determined. Animals were killed, and bacterial titers
were enumerated from organs by plating.
Ethical Framework. Animal studies were either approved by the local gov-
ernment of Franconia, Germany (approval nos. 2531.01-06/12 and 2532-2-
155) and performed in strict accordance with the guidelines for animal care
and experimentation of German Animal Protection Law or were approved
under the Animal (Scientific Procedures) Act 1986 (Project license 30/2825)
and were approved by the University of Oxford Animal Care and Ethical
Review Committee. Both sites conformed to Directive 2010/63/EU of the
European Union. Work with human neutrophils was approved by the Ethics
Commission of the University of Wuerzburg (Code 2015091401). Patient P
isolates were obtained during participation in a study of S. aureus carriage in
Oxfordshire. This study was approved by Oxfordshire Research Ethics Com-
mittee B (approval reference 08/H0605/102 granted September 2, 2008) and
obtained individual written consent from all participants. Patient S isolates
were collected from routine clinical samples. Ethical approval for sequencing
S. aureus isolates from routine clinical samples and linkage to patient data
without individual patient consent in Oxford and Brighton in the U.K. was
obtained from Berkshire Ethics Committee (10/H0505/83) and the U.K. Na-
tional Information Governance Board [8-05(e)/2010].
For additional experimental details, please see SI Appendix, SI Materials
and Methods.
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